References

Assouline S Miller WH Jr. (2006) High-dose vitamin C therapy: Renewed hope or false promise? Canadian Medical Association Journal 174:956-7

Benade L Howard T Burk D (1969) Synergistic killing of Ehrlich ascites carcinoma cells by ascorbate and 3-amino-1,2,4-triazole. Oncol 23:33-43

Bland J (1995) Vitamin C: The future is now. Keats Publishing, Inc. New Canaan, Connecticut

Block G Schwarz R (1994) Ascorbic Acid and Cancer: Animal and Cell Culture Data. in Natural Antioxidants in Human Health and Disease, (Balz Frei ed.), Academic Press, New York pp. 129-153

Bush MJ Verlangieri AJ (1987) An acute study of the relative gastro-intestinal absorption of a novel form of calcium ascorbate. Res Comm Chem Pathol Pharmacol 57:137-40

Bussey HJR. DeCosse JJ Deschner EE et al. (1982) A randomized trial of ascorbic acid in polyposis Coli. Cancer 50:1434-1439

Byers T Guerrero N (1995) Epidemiological evidence for vitamin C and vitamin E in cancer prevention. Am J Clin Nutr 62:1385S-1392S

Byers T Perry G (1992) Dietary carotenes, vitamin C, and vitamin E as protective antioxidants in human cancers. Ann Rev Nutr 12:139-59

Cameron E (1966) Hyaluronidase and Cancer. Pergamon Press, Oxford

Cameron E (1976) Biological function of ascorbic acid and the pathogenesis of scurvy: A working hypothesis. Med Hypoth 154-63

Cameron E (1982) Vitamin C and Cancer: an Overview. In Vitamin C, New Clinical Applications. Hanck A (Ed.) Huber, Bern, p. 115-127

Cameron E (1986) Vitamin C and cancer cachexia: the carnitine connection. In Huemer RP (ed.), The roots of molecular medicine: A tribute to Linus Pauling. WH Freeman and Co, New York pp. 133-9

Cameron E (1991) Protocol for the use of vitamin C in the treatment of cancer. Medical Hypotheses 36:190-4

Cameron E Baird GM (1973) Ascorbic acid and dependence on opiates in patients with advanced disseminated cancer. Int Research Communication Systems (IRCS) August, p. 38:

Cameron E Campbell A Plenderleith W (1961) Seromucoid in the diagnosis of cancer. Scottish Med J 6:301-307

Cameron E Campbell A (1974) The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic acid supplementation in advanced human cancer. Chem Biol Interact 9:285-15

Cameron E Campbell A (1991) Innovation vs. Quality Control: An Unpublished Clinical Trial on Supplemental Ascorbate in Incurable Cancer, Medical Hypotheses, 36:185-189

Cameron E Campbell A Jack T (1975) The orthomolecular treatment of cancer. III.. Reticulum cell sarcoma: double complete regression induced by high-dose ascorbic acid therapy. Chem Biol Interact 11:387-93

Cameron E Pauling L (1973) Ascorbic acid and the glycosaminoglycans: an orthomolecular approach to cancer and other diseases. Oncology 27:181-92

Cameron E Pauling L (1976) Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer. PNAS USA 73:3685-9

Cameron E Pauling L (1978) Supplemental ascorbate in the supportive treatment of cancer: Reevaluation of prolongation of survival times in terminal human cancer. PNAS USA 75:4538-42

Cameron E Pauling L (1993) Cancer and Vitamin C. Camino Books, Philadelphia, 278 pages.

Cameron E Rotman D (1972) Ascorbic acid, cell proliferation and cancer. Lancet I. 542, 1972

Campbell A Jack T (1979) Acute reactions to mega ascorbic acid therapy in malignant disease. Scott Med J 24:151-3

Campbell A, Jack T, Cameron E. (1991) Reticulum cell sarcoma: two complete 'spontaneous' regressions, in response to high-dose ascorbic acid therapy. A report on subsequent progress. Oncology 48:495-7.

Casciari JJ, Riordan HD, Miranda-Massari JR, Gonzalez MJ. (2005) Effects of high dose ascorbate administration on L-10 tumor growth in guinea pigs. P R Health Sci J. 24:145-50.

Casciari JJ Riordan NH Schmidt TL Meng XL Jackson JA Riordan HD (2001) Cytotoxicity of ascorbate, lipoic acid, and other antioxidants in hollow fibre in vitro tumours. Brit J Can 84:1544-50

Cathcart RF (1981) Vitamin C, Titrating to Bowel Tolerance, Anascorbemia, and Acute Induced Scurvy. Medical Hypoth 7:1359-76

Cheraskin E Ringsdorf WM Hutchins K Setyaamadja ATSH Wideman GL (1968) Effect of diet upon radiation response in cervical carcinoma of the uterus: A preliminary report. Acta Cytologica 12:433-8

Creagan ET Moertel CG (1980) correspondance relating to 1^st Mayo Clinic study. N Eng J Med 302:299-300

Creagan ET Moertel CG O’Fallon JR Schutt AJ O’Connell MJ Rubin J Frytak S (1979) Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer: A controlled trial. N Engl J Med 301:687-90

DeCosse JJ Adams MB Kuzma JF LoGerfo P Condon RE (1975) Effects of ascorbic acid on rectal polyps of patients with familial polyposis. Surgery 78:608-612

Dion PW Bright-See EB Smith CC Bruce WR (1983) The effect of dietary ascorbic acid and alpha-tocopherol on fecal mutagenicity. Mutat Res 102:27-37

Lesperance ML Olivotto IA Forde N Zhao Y Speers C Foster H Tsao M MacPherson N Hoffer A (2002) Mega-dose vitamins and minerals in the treatment of non-metastatic breast cancer: an historical cohort study: an historical cohort study. Breast Cancer Res Treat 76:137-43

Fay MJ Verlangieri AJ (1991) Stimulatory action of calcium threonate on ascorbic acid uptake by a human T-lymphoma cell line. Life Sciences 49:1377-81

Fontham ETH (1994) Vitamin C, Vitamin C-Rich Foods, and cancer: Epidemiological Studies. In Frei B (Ed.) Natural Antioxidants in Human Health and Disease, Academic Press, New York, pp. 157-197

Garb S (1968) Cure for Cancer: A National Goal. Springer, New York

Garnier L Blanc M (1963) Absorption intestinale de solutions de sorbitol dans diverses conditions physiologique. J de Physiol (Paris) 55:254-5

Goertzel T Goertzel B (1995) Linus Pauling: A Life in Science and Politics. Basic Books, New York

Goertzel TG Goertzel MG Goertzel V (1980) Linus Pauling: The Scientist as Crusader. Antioch Rev 38:371-82

Gonzales MJ Miranda-Massari JR Mora EM Jimenez IZ Matos MI Riordan HD Casciari JJ Riordan NH Rodriguez M Guzman A (2002) Orthomolecular Oncology: a Mechanistic View of Intravenous Ascorbate’s Chemotherapeutic Activity. Puerto Rican Health Sciences Journal 21:39-41

Hager T (1995) Force of Nature: The Life of Linus Pauling. Simon & Schuster, New York

Hager T (1998) Linus Pauling and the Chemistry of Life. Oxford University Press, New York

Hanck A (1986) Ascorbic Acid and Cancer. In Meyskens FL Jr Prasad KN (Eds.) Vitamins and Cancer, Human Cancer Prevention by Vitamins and Micronutrients, Humana Press, Clifton, NJ pp.365-397

Hanck AB (1988) Vitamin C and Cancer. In Prog Clin Biol Res 259:307-20, this volume also referred to as: "Nutrition, Growth, and Cancer", (Eds.) Tryfiates GP Prasad KN, Alan R. Liss Inc.,

Harmon D (1956) Aging: A theory based on free radical and radiation Chemistry. J Gerontol 11:298-300

Heise E Luhrs W Neunhoeffer O (1957) Der Einfluss von Dehydroascorbinsaure auf den Tumorstoffwechsel. Naturwissenschaft 15:42

Hoffer, A (1995) Orthomolecular Treatment of Cancer. In Prasad KN Santamaria L Williams RM (eds.), Nutrients in Cancer Prevention and Treatment. Humana Press, Totowa, NJ Pp.373-391

Hoffer LJ (2001) Proof versus plausibility: rules of engagement for the struggle to evaluate alternative cancer therapies. CMAJ 164:351-3

Hoffer A Pauling L (1990) Hardin Jones Biostatistical Analysis of Mortality Data for Cohorts of Cancer Patients with a Large Fraction Surviving at the Termination of the Study and a Comparison of Survival Times of Cancer Patients Receiving Large Regular Doses of Vitamin C and Other Nutrients with Similar Patients Not Receiving Those Doses. J Orthomol Med 5:143-154

Hoffer A Pauling L (1993) Hardin Jones Biostatistical Analysis of Mortality Data for a Second Set of Cohorts of Cancer Patients with a Large Fraction Surviving at the Termination of the Study and a Comparison of Survival Times of Cancer Patients Receiving Large Regular Doses of Vitamin C and Other Nutrients with Similar Patients Not Receiving Those Doses. J Orthomol Med 8:154-167

Huber L (1953) Die Hypervitaminisierung mit vitamin A und vitamin C bei inoperabelen Gebärmutterkrebsen. Zentralbl Gynaecol 75:1771-7

Jaffey M (1982) Vitamin C and Cancer: Examination of the Vale of Leven Trial Results Using Broad Inductive Reasoning. Med Hypoth 8:49-84

Jorissen WP (1955) Induced oxidation in carcinoma cases. Chem Weekblad 51:705-706

Kahr E (1959) Erfahrungen mit der zusatzlichen Allgemeinbehandlung beim Krebskranken. Med Klin 54:63-6

Kalokerinos A, Dettman I, Dettman G. (1982) Ascorbate--the proof of the pudding! A selection of case histories responding to ascorbate. Australasian Nurses J. 11:18-21

Kim K Park S Jung CW Lee MH Park K Lee J Riordan NH Riordan HD Kimler BF Park CH (2003) Manipulation of L-ascorbic acid (LAA) to extremes in the treatment of acute myeloid leukemia (AML): Clinical responses supported by molecular mechanism. Proc Am Soc Clin Oncol 22:609 (abstract 2448)

Kimoto E Tanaka H Gyotoku J Morishige F Pauling L (1983) Enhancement of antitumor activity of ascorbate against Ehrlich ascites tumor cells by the copper:glycylglycylhistidine complex. Can Res 43:824-8

Klenner FR (1971) Observations on the dose and administration of ascorbic acid when employed beyond the range of a vitamin in human pathology. J Appl Nutr 23:61-88

Lamm DL et al (1994) Megadose vitamins in bladder cancer: a double blind clinical trial. J Urol 151:21-6

Lenhartz M (1949) Zur heilung des Karzinoms durch Uberdosierung mit A-Vitamin. Zeitschrift fur die Gesamte Innere Medzin und ihre Grenzebebiete (Stuttgart) 4:267-9

Life Extension Foundation (2003) Disease Prevention and Treatment, Expanded fourth Edition, Life Extension Media, Hollywood, FL

Liotti FS Bodo M Menghini AR Guerrieri P Pezzetti F (1986) Antagonism between catalase and ascorbic acid in control of normal and neoplastic cell multiplication. Cancer Lett 33:99-106

Liotti FS, Pelliccia C, Pezzetti F. (1988) Different response of chicken embryo fibroblasts and hepatocytes to the interference of certain antioxidants on the binding of [G-3H]benzo[a]pyrene to DNA. Cancer Lett. 41(2):235-42.

Lührs W Bacigalupo J (1959) An Animal Test and a Clinical Experiment to Influence Tumorous Growth by Dehydroascorbic Acid. J Egypt Med Assoc 42:278-281

McKeown-Eyssen G Holloway C Jazmaji V Bright-See E Dion P Bruce WR (1988) A randomized trial of vitamins C and E in the prevention of recurrence of colorectal polyps. Cancer Res 48:4701-5

Mead C Hager T (2001) Linus Pauling: Scientist and Peacemaker. Oregon State University Press, Corvallis

Meyer BA Exner GC (1953) A treatment for inoperable cancer and an adjunct to all other forms of treatment. Med Press 230:651-4

Meyer, BA Orgel, IS (1950) The cancer patient. A new chemotherapy in advanced cases, Churchill, London

Meyer BA Orgel IS (1949) Med Press 24: 8

Miegl H (1958) Uber die Anwendung von Vitamin C in der Hals-, Nasen-, Ohren-Heilkunde. Wiener Medizinische Wochenschrift 108:859-864 (No. 42)

Morishige F Murata A (1979) Prolongation of survival times in terminal human cancer by administration of supplemental ascorbate. J Int Acad Prev Med 5:47-52

Moertel C (1986) Ascorbic acid does not cure cancer. Nutr Reviews 44: 30-31

Moertel CG Fleming TR Creagan ET Rubin J Oconnell MJ Ames MM (1985) High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy: A randomized double-blind comparison. N Engl J Med 312:137-141

Moertel CG Fleming TR Rubin J et al (1982) A clinicl trial of amygdalin (Laetrile) in the treatment of human cancer. N Engl J Med 306:201-6

Morishige F Nakamura T Nakamura N Morishige N (1986) The role of vitamin C in tumor therapy (human). In Meyskens FL Jr Prasad KN (Eds.) Vitamins and Cancer, Human Cancer Prevention by Vitamins and Micronutrients. Humana Press, Clifton, New Jersey

Moss R (1991) The Cancer Industry. Paragon House, New York

Murata A Morishige F Yamaguchi H (1982) Prolongation of survival times of terminal cancer patients by administration of large doses of ascorbate. In Hanck A (ed.), Vitamin C: New Clinical Applications. Huber, Bern pp. 103-13 [This is also: Int J Vitam Nutr Res Suppl 23]

Newbold HL (1981) Vitamin C Against Cancer. Stein and Day, Briarcliff Manor, NY

Padayatty SJ Katz A Wang Y Eck P Kwon O Lee JH et al (2003) Vitamin C as an antioxidant: Evaluation of its role in disease prevention. J Am Coll Nutr 22:18-35

Padayatta SJ Levine M (2000) Reevaluation of ascorbate in cancer treatment: emerging evidence, open minds and serendipidity. J Am Coll Nutr 19:423-5

Padayatty SJ Riordan HD Hewitt SM Katz A Hoffer J Levine M (2006) Intravenously administered vitamin C as cancer therapy: three cases. Canadian Medical Association Journal 174:937-42

Paganelli GMBiasco G Brandi G Santucci R Gizzi G Villani V Cianci M Miglioli M Barbara L (1992) Effect of vitamin A, E, and C Supplementation on rectal cell proliferation in patients with colorectal adenomas. J Natl Cancer Inst 84:47-51

Pauling L (1958) No More War! Dodd, Mead & Company, New York

Pauling L (1968) Orthomolecular Psychiatry. Science 160:265-71

Pauling L (1970) Vitamin C and the Common Cold. W. H. Freeman and Co., San Francisco

Pauling L (1982) [Remarks made as chairman of conference session] II. Workshop on Vitamin C in immunology and cancer. In: Vitamin C, A. Hanck (Ed.) pp. 209- 219, Hans Huber, Bern [This volume is also identified as Int J Vit Nutr Res, Suppl No. 23]

Pauling L (1983) Vitamin C, the Common Cold & the Flu. Berkley revised edition, Berkley Books, New York

Pauling L (1986) How to Live Longer and Feel Better. W. H. Freeman, New

Pauling L Herman ZS (1989) Criteria for the validity of clinical trials of treatments of cohorts of cancer patients based on the Hardin Jones principle. PNAS USA 86:6835-7

Poydock ME Harguindey S Hart T Takita H Kelly D (1985) Mitogenic inhibition and effect on survival of mice bearing L1210 leukemia using a combination of dehydroascorbic acid and hydroxycobalamin. Am J Clin Oncol (CCT) 8:266-269

Poydock ME Reikert D Rice J (1982) Influence of vitamins C and B₁₂ on the survival rate of mice bearing ascites tumor. Expl Cell Biol 50:88-91

Piche E Weghaupt K (1956) Ueber die Behandlung mit Vitamin A und C in hohen Dosen bei weit fortgeschrittenen Karzinomen des weiblichen Genitaltraktes. [Treatment of advanced carcinomas of female genitalia with large doses of vitamin A and C.] Wiener Medizinische Wochenschrift 106:391-392

Richards E (1988) The politics of therapeutic evaluation: The vitamin C and cancer controversy. Soc Stud Sci 18:653-701

Richards E. (1991) Vitamin C and Cancer: Medicine or Politics? New York:St. Martin’s Press

Riordan, H (2003) The use of high dose intravenous vitamin C in cancer and other diseases - A 28-year perspective. Speech presented at a meeting of The American College for Advancement in Medicine, The Bio-Communications Research Institute, Wichita, KA, May 17, 2003

Riordan HD, Casciari JJ, Gonzalez MJ, Riordan NH, Miranda-Massari JR, Taylor P, Jackson JA. (2005) A pilot clinical study of continuous intravenous ascorbate in terminal cancer patients. Puerto Rican Health Sci J. 2005 Dec;24(4):269-76

Riordan HD Hunninghake RB Riordan NH Jackson JJ Meng X Taylor P Casciari JJ Gonzalez MJ Miranda-Massari JR Mora EM Rosario N Rivera A (2003) Intravenous Ascorbic Acid: Protocol for its Application and Use. P. R. Health Sci. J. 22, 287–290.

Riordan HD Jackson JA Schultz M (1990) Case Study: High-dose intravenous vitamin C in the treatment of a patient with adenocarcinoma of the kidney. J Orthomol Med 5: 5-7

Riordan NH Riordan HD Casciari JP (2000) Clinical and Experimental Experiences with Intravenous Vitamin C. J Orthomol Med 15:201-213

Riordan, NH Riordan HD Meng X Li Y Jackson JA (1995) Intravenous ascorbate as a tumor cytotoxic chemotherapeutic agent. Med Hypoth 44:207-13

Schirmacher H Schneider J (1955) Grenzen und Moglichkeiten der Vitamin-A und Vitamin-C -Ubervitaminizierung bei inoperablen und strahlenresistenten Karzinomen [Limits and possibilities of supervitaminization for inoperable and X-ray resistant carcinoma.]. Zeitschrift fur Geburtshilfe und Gyanaekologie 144:172-182

Schneider E (1954) Vitamine C und A beim Karzinom: ein Beitrag zur Hypervitaminsierungstherapie der Krebskranken. Deutsche Med Wochenschr 79:584-6

Serafini A (1989) Linus Pauling; A Man and His Science. Paragon House, New York

Shoyab M (1981) Inhibition of the binding of 7,12-dimethylbenz[alpha]anthracene to DNA of murine epidermal cells in culture by vitamin A and vitamin C. Oncology 38:187-192

Sun M (1981) At long last, Linus Pauling lands NCI grant. Science 212:1126-7

Trizna Z Schantz SP Lee JJ Spitz MR Goepfert H et al. (1993) In Vitro protective effects of chemopreventive agents against bleomycin-induced genotoxicity in lymphoblastoid cell lines and peripheral lymphocytes of head and neck cancer patients. Cancer Detect Prevent 17:575-583

Tsao CS (1991) Inhibiting effect of ascorbic acid on the growth of human mammary tumor xenografts. Am J Clin Nutr 54:1274S-80S

Tsao CS Salimi SL (1984) Evidence of rebound effect with ascorbic acid. Med Hypoth 13:303-10

Tschetter L Creagan ET O’Fallon JR Shutt AJ Krook HE Windschitl HE Reuter NF Pfeifle DM (1983) A community-based study of vitamin C (ascorbic acid) therapy in patients with advanced cancer. Proceed Amer Soc Clin Oncol 2:92

Van der Merwe CF. (1993) The reversibility of cancer, 10 years on. S Afr Med J. 83(1):69

Waddell WA Gerner RE (1980) Indomethacin and Ascorbate Inhibit Desmoid Tumors. Journal of Surg Oncol 15:85-90

von Wendt (1949) Zeitschrift fur die Gesamte Innere Medzin und ihre Grenzebebiete (Stuttgart) 4:267

von Wendt G (1950) Zur Anwendung der Ubervitaminizierungtherapie von Wendt. Zeitschrift fur die Gesamte Innere Medzin und ihre Grenzebebiete (Stuttgart) 5:255

Wendt (1951) Zeitschrift fur die Gesamte Innere Medzin und ihre Grenzebebiete (Stuttgart) 6, 7/8, 255-

Yamafuji K Nakamura Y Omura H Soeda T Gyotoku K (1971) Antitumor potency of ascorbic, dehydroascorbic or 2,3-diketogulonic acid and their action on deoxyribonucleic acid. Z Krebsforsch 76:1-7

Zalchikova KN Vladinurova VS (1957) Use of Ascorbic Acid for Cancer of Cervix of uterus. Vestnik Rentgenol Radiol 32:4-5